Opinion: We Need More than New Antibiotics to Fight Resistance
Opinion: We Need More than New Antibiotics to Fight Resistance
Metabolic disrupters, phages, and other approaches are going to be needed to treat the broadest possible range of patients infected by bacterial pathogens resistant to multiple drugs.
Opinion: We Need More than New Antibiotics to Fight Resistance
Opinion: We Need More than New Antibiotics to Fight Resistance

Metabolic disrupters, phages, and other approaches are going to be needed to treat the broadest possible range of patients infected by bacterial pathogens resistant to multiple drugs.

Metabolic disrupters, phages, and other approaches are going to be needed to treat the broadest possible range of patients infected by bacterial pathogens resistant to multiple drugs.

opinion
Opinion: Boycotting Elsevier Is Not Enough
Opinion: Boycotting Elsevier Is Not Enough
Shaun Khoo | Oct 22, 2019
The publishing giant will likely survive the latest boycott by scientists. An overhaul is needed to make science publishing fair and open.
Opinion: The Nature of Social Inequalities in Great Britain
Opinion: The Nature of Social Inequalities in Great Britain
Abdel Abdellaoui, Judy Luigjes | Oct 21, 2019
Regional differences in wealth in the UK are tied to genetic variants related to education—and migration is only widening the gap.
Opinion: Scientists Need to Demand Better Antibody Validation
Opinion: Scientists Need to Demand Better Antibody Validation
Peter S. McPherson | Oct 15, 2019
My lab has developed a protocol to easily assess the specificity of antibodies—and hopefully stem some of the reproducibility crisis.
Opinion: Taxpayers Should Cover Portion of Patent Costs
Opinion: Taxpayers Should Cover Portion of Patent Costs
Paul R. Sanberg | Oct 9, 2019
Federal grant support for technology transfer at universities will strengthen the national innovation system.
Opinion: Can Prizes Help Women Shatter Science’s Glass Ceiling?
Opinion: Can Prizes Help Women Shatter Science’s Glass Ceiling?
Marja Makarow | Oct 2, 2019
As we await the announcement of the 2019 Nobel Prize winners, it’s time to question why female scientists still lag behind their male colleagues.
Opinion: Develop Organoids, Not Chimeras, for Transplantation
Opinion: Develop Organoids, Not Chimeras, for Transplantation
John D. Loike and Robert Pollack | Oct 1, 2019
Scientists are devising human-animal hybrids for harvesting human organs, but lab-derived mini-organs are a less ethically fraught solution to meeting the need for transplantation.
Opinion: Biomarkers of Longevity Not Ready for the Clinic
Opinion: Biomarkers of Longevity Not Ready for the Clinic
John D. Loike and Ruth L. Fischbach | Sep 27, 2019
The science isn’t there yet, nor are the known interventions that ought to be combined with delivering such predictions.
Opinion: Why It Is Time to Make Conferences Worth It
Opinion: Why It Is Time to Make Conferences Worth It
Nicholas Rowe | Sep 26, 2019
Very little science from meetings reaches a meaningfully large audience.
Opinion: Are 71 NCI-Designated Cancer Centers Too Many?
Opinion: Are 71 NCI-Designated Cancer Centers Too Many?
David Rubenson | Aug 29, 2019
A program to encourage transdisciplinary research at top cancer centers has evolved into a counterproductive national strategy for organizing cancer research.